96 related articles for article (PubMed ID: 3035067)
1. Respiratory virus infection of peripheral blood monocytes: correlation with ageing of cells and interferon production in vitro.
Krilov LR; Hendry RM; Godfrey E; McIntosh K
J Gen Virol; 1987 Jun; 68 ( Pt 6)():1749-53. PubMed ID: 3035067
[TBL] [Abstract][Full Text] [Related]
2. Production of interferon alpha by dengue virus-infected human monocytes.
Kurane I; Ennis FA
J Gen Virol; 1988 Feb; 69 ( Pt 2)():445-9. PubMed ID: 3339332
[TBL] [Abstract][Full Text] [Related]
3. Respiratory syncytial virus infection of human cord and adult blood monocytes and alveolar macrophages.
Midulla F; Huang YT; Gilbert IA; Cirino NM; McFadden ER; Panuska JR
Am Rev Respir Dis; 1989 Sep; 140(3):771-7. PubMed ID: 2476959
[TBL] [Abstract][Full Text] [Related]
4. Comparison of differing cytopathic effects in human airway epithelium of parainfluenza virus 5 (W3A), parainfluenza virus type 3, and respiratory syncytial virus.
Zhang L; Collins PL; Lamb RA; Pickles RJ
Virology; 2011 Dec; 421(1):67-77. PubMed ID: 21986028
[TBL] [Abstract][Full Text] [Related]
5. Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response.
Young DF; Didcock L; Goodbourn S; Randall RE
Virology; 2000 Apr; 269(2):383-90. PubMed ID: 10753717
[TBL] [Abstract][Full Text] [Related]
6. Genetic stability of RSV-F expression and the restricted growth phenotype of a live attenuated PIV3 vectored RSV vaccine candidate (MEDI-534) following restrictive growth in human lung cells.
Nelson CL; Tang RS; Stillman EA
Vaccine; 2013 Aug; 31(36):3756-62. PubMed ID: 23623857
[TBL] [Abstract][Full Text] [Related]
7. Regulation of HIV replication in infected monocytes by IFN-alpha. Mechanisms for viral restriction.
Gendelman HE; Baca LM; Turpin J; Kalter DC; Hansen B; Orenstein JM; Dieffenbach CW; Friedman RM; Meltzer MS
J Immunol; 1990 Oct; 145(8):2669-76. PubMed ID: 1976701
[TBL] [Abstract][Full Text] [Related]
8. Effect of macrophages and in vitro infection with parainfluenza type 3 and respiratory syncytial viruses on the mitogenic response of bovine lymphocytes.
Adair BM; Bradford HE; Mackie DP; McNulty MS
Am J Vet Res; 1992 Feb; 53(2):225-9. PubMed ID: 1315492
[TBL] [Abstract][Full Text] [Related]
9. Establishment of persistent infection by parainfluenza virus type 3: role of a syncytium inhibitor.
Hodes DS; Weldy PL; Doundoulakis JH
J Gen Virol; 1979 Aug; 44(2):515-23. PubMed ID: 230293
[TBL] [Abstract][Full Text] [Related]
10. Respiratory syncytial virus infection of human primary nasal and bronchial epithelial cell cultures and bronchoalveolar macrophages.
Becker S; Soukup J; Yankaskas JR
Am J Respir Cell Mol Biol; 1992 Apr; 6(4):369-74. PubMed ID: 1550681
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of parainfluenza virus type 3 on human monocytes and dendritic cells.
Plotnicky-Gilquin H; Cyblat D; Aubry JP; Delneste Y; Blaecke A; Bonnefoy JY; Corvaïa N; Jeannin P
Virology; 2001 Jun; 285(1):82-90. PubMed ID: 11414808
[TBL] [Abstract][Full Text] [Related]
12. Induction of IFN-alpha in peripheral blood mononuclear cells by HIV-infected monocytes. Restricted antiviral activity of the HIV-induced IFN.
Gendelman HE; Baca LM; Kubrak CA; Genis P; Burrous S; Friedman RM; Jacobs D; Meltzer MS
J Immunol; 1992 Jan; 148(2):422-9. PubMed ID: 1729362
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of the recombinant human parainfluenza virus type 3 cp45 candidate vaccine virus is augmented by importation of the respiratory syncytial virus cpts530 L polymerase mutation.
Skiadopoulos MH; Surman SR; St Claire M; Elkins WR; Collins PL; Murphy BR
Virology; 1999 Jul; 260(1):125-35. PubMed ID: 10405364
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in the respiratory tracts of human infants following paramyxovirus infection.
Elliott MB; Welliver RC; Laughlin TS; Pryharski KS; LaPierre NA; Chen T; Souza V; Terio NB; Hancock GE
J Med Virol; 2007 Apr; 79(4):447-56. PubMed ID: 17311330
[TBL] [Abstract][Full Text] [Related]
15. Restricted replication of respiratory syncytial virus in human alveolar macrophages.
Cirino NM; Panuska JR; Villani A; Taraf H; Rebert NA; Merolla R; Tsivitse P; Gilbert IA
J Gen Virol; 1993 Aug; 74 ( Pt 8)():1527-37. PubMed ID: 8345347
[TBL] [Abstract][Full Text] [Related]
16. Ozone effect on respiratory syncytial virus infectivity and cytokine production by human alveolar macrophages.
Soukup J; Koren HS; Becker S
Environ Res; 1993 Feb; 60(2):178-86. PubMed ID: 8472647
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma protects primary monocytes against infection with human immunodeficiency virus type 1.
Fan SX; Turpin JA; Aronovitz JR; Meltzer MS
J Leukoc Biol; 1994 Sep; 56(3):362-8. PubMed ID: 8083609
[TBL] [Abstract][Full Text] [Related]
18. Epithelial cells infected with respiratory syncytial virus are resistant to the anti-inflammatory effects of hydrocortisone.
Bonville CA; Mehta PA; Krilov LR; Rosenberg HF; Domachowske JB
Cell Immunol; 2001 Nov; 213(2):134-40. PubMed ID: 11831875
[TBL] [Abstract][Full Text] [Related]
19. Current status of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccine development: memorandum from a joint WHO/NIAID meeting.
Murphy BR; Collins PL
Bull World Health Organ; 1997; 75(4):307-13. PubMed ID: 9342889
[TBL] [Abstract][Full Text] [Related]
20. Respiratory syncytial virus strain A2 is resistant to the antiviral effects of type I interferons and human MxA.
Atreya PL; Kulkarni S
Virology; 1999 Sep; 261(2):227-41. PubMed ID: 10497108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
